Benitec Biopharma, Inc. (BNTC)
12.72
+0.04
(+0.35%)
USD |
NASDAQ |
Sep 08, 16:00
12.73
0.00 (0.00%)
Pre-Market: 20:00
Benitec Biopharma Price to Book Value : 2.384 for Sept. 8, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 2.384 |
| September 04, 2026 | 2.376 |
| September 03, 2026 | 2.331 |
| September 02, 2026 | 2.414 |
| September 01, 2026 | 2.307 |
| August 31, 2026 | 2.280 |
| August 28, 2026 | 2.337 |
| August 27, 2026 | 2.374 |
| August 26, 2026 | 2.414 |
| August 25, 2026 | 2.440 |
| August 24, 2026 | 2.382 |
| August 21, 2026 | 2.526 |
| August 20, 2026 | 2.438 |
| August 19, 2026 | 2.507 |
| August 18, 2026 | 2.414 |
| August 17, 2026 | 2.449 |
| August 14, 2026 | 2.354 |
| August 13, 2026 | 2.354 |
| August 12, 2026 | 2.312 |
| August 11, 2026 | 2.526 |
| August 10, 2026 | 2.582 |
| August 07, 2026 | 2.554 |
| August 06, 2026 | 2.460 |
| August 05, 2026 | 2.378 |
| August 04, 2026 | 2.346 |
| Date | Value |
|---|---|
| August 03, 2026 | 2.277 |
| July 31, 2026 | 2.194 |
| July 30, 2026 | 2.222 |
| July 29, 2026 | 2.258 |
| July 28, 2026 | 2.228 |
| July 27, 2026 | 2.17 |
| July 24, 2026 | 2.149 |
| July 23, 2026 | 2.144 |
| July 22, 2026 | 2.144 |
| July 21, 2026 | 2.228 |
| July 20, 2026 | 2.243 |
| July 17, 2026 | 2.395 |
| July 16, 2026 | 2.372 |
| July 15, 2026 | 2.440 |
| July 14, 2026 | 2.432 |
| July 13, 2026 | 2.434 |
| July 10, 2026 | 2.515 |
| July 09, 2026 | 2.526 |
| July 08, 2026 | 2.526 |
| July 07, 2026 | 2.518 |
| July 06, 2026 | 2.474 |
| July 02, 2026 | 2.477 |
| July 01, 2026 | 2.378 |
| June 30, 2026 | 2.507 |
| June 29, 2026 | 2.380 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.633 |
| Alnylam Pharmaceuticals, Inc. | 25.69 |
| Anika Therapeutics, Inc. | 2.051 |
| Savara, Inc. | 7.907 |
| Vericel Corp. | 5.404 |
Price to Book Value Related Metrics
| Price | 12.72 |
| Earnings Yield | -7.30% |
| Market Cap | 437.16M |